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Hyperlipoproteinemia in experimental chronic renal insuffi-
ciency of the rat. Lipid metabolism was studied in experimental
uremia. Uremic (U) rats were compared with sham-operated, pair-
fed (PF) controls and with ad-jib-fed (AL) controls. In U animals,
fasting glucose concentrations were normal, immunoreactive
serum insulin (IRI) levels were decreased, and immunoreactive
glucagon levels were increased. A significant increase in the serum
concentration of all lipid classes was observed: triglycerides were
elevated 10-fold above the values in PF and AL controls: phospho-
lipids, twofold: total cholesterol, threefold; and free cholesterol,
sixfold. Cholesterol concentration was increased in beta- and pre-
beta-lipoproteins and even more so in alpha- and pre-aipha-lipo-
proteins. There was an increase in the ratio of free cholesterol/total
cholesterol. The fatty acid composition of serum lipoproteins was
unchanged. Concomitantly, in liver tissue, there was no change in
lipid content (triglyceride, cholesterol) and fatty acid composition.
These findings argue against glucose- or insulin-mediated changes
in hepatic de novo fatty acid synthesis, chain elongation, or poly-
desaturation. In U animals, the HMG-CoA-reductase activity of
liver microsomes was slightly, but not significantly, reduced as
was tritiated water incorporation into cholesterol in isolated per-
fused liver preparations. In adipose tissue, there was a decrease in
triglyceride content. The results provide evidence against insulin-
mediated hepatic overproduction as a major cause of hyperlipo-
proteinemia in this model of experimental renal insufficiency and
point to peripheral under-utilization of lipoproteins.
Hyperlipoprotéinémie tie l'insuffisance rénale expérimentale
chez le rat. Le mCtabolisme des lipides a etC étudié dans l'urCmie
expérimentale, Des rats urémiques (U) ont été compares a des
témoins ayant subi un simulacre dintervention et nourris de facon
identique (PF) et a des témoins nounis ad lib (AL). Chez les
animaux U Ia glycémie àjeun est normale, l'insuline immunorCac-
tive sCrique (IRI) est diminuCe et le glucagon immunorCactif est
augmenté. Une augmentation significative de toutes les classes de
lipides seriques est observCe. Les triglycerides sont supCrieurs de
10 fois aux valeurs de PF et de AL, les phospholipides de deux
fois, le cholesterol total de trois fois et Ic cholesterol libre de six
fois, La concentration de cholesterol est augmentee dans les beta
et les prC-bCta lipoprotéines et plus encore dans les alpha et pré-
alpha Iipoprotéines. II y a une augmentation du rapport cholesterol
libre/cholestérol total. La composition des lipoprotéines sCriques
en acides gras n'est pas modifide. 11 n'y a pas de modification
parailCle, dans Ic tissu hCpatique, du contenu en lipides (triglycer-
ides, cholesterol) et de Ia composition en acides gras. Ces consta-
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tations plaident contre des modilications, dépendantes du glucose
ou de l'insuline, de la synthese hépatique de novo des FA, de
lallongement des chaInes ou de Ia polydesaturation. Chez les
animaux U, l'activite de Ia HMG-CoA rCductase des microsomes
hépatiques est lCgCrement, mais non significantivement, reduite,
de mCme que l'incorporation de 3H,O dans Ic cholesterol du foie
isolé perfuse. Dans le tissu adipeux Ia concentration de triglyceride
diminue. Ces résultats apportent des arguments contre une hyper-
production hepatique, dépendante de l'insuline, comme cause
majeure d'hyperlipoprotéinemie dans cc modCle d'insuffisance rd-
nale experimentale et orientent vers une diminution de l'utilisation
pCriphCrique des lipoprotéines.
Recent interest in the hyperlipoproteinemia of re-
nal insufficiency [11 stems mainly from its suspected
role as a risk factor for cardiovascular disease in
dialyzed patients [21. The pathogenesis of hyperlipo-
proteinemia in renal insufficiency remains unsettled
[3]. Research in this field is hampered by the lack of
a suitable experimental model. In spite of known
species differences in lipid metabolism, the subto-
tally nephrectomized, chronically uremic rat does
provide such a model. The following investigation
documents that hyperlipoproteinemia develops in
uremic rats. The results provide evidence against
hepatic overproduction as a major cause of hyper-
lipoproteinemia and point to peripheral under-utiliza-
tion of lipoproteins.
Methods
Experimental protocol. Male, Sprague Dawley
rats (body wt, 140 to 180 g) were randomized into
three groups and matched on the basis of food con-
sumption. The first group was made uremic as de-
scribed elsewhere [41 (two-stage 8/10 nephrectomy:
subtotal nephrectomy of one kidney with irradiation
of parenchyma with 1,000 rad, followed by resection
of the contralateral kidney after 8 days). Control
animals were sham-operated (decapsulation of kid-
ney). The animals were kept in single cages at con-
stant temperature (250 C) and humidity and were
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exposed to a 12-hr on and a 12-hr off light cycle.
Food was offered from six o'clock PM to six o'clock
AM. Nephrectomized rats had free access to water
and rat chow pellets (Altromin®, 3.3 kilocalories/g;
17.5% protein per body wt). Pair-fed, sham-operated
rats received an amount of food corresponding to
what had been consumed by the matched uremic
animals the day before. Ad-lib-fed, sham-operated
animals had free access to food and water.
Every 6 to 7 days, a blood sample (1 ml) was taken
following overnight fasting by puncture of the oph-
thalmic plexus. Blood samples were centrifuged at 40
C, and the serum samples were distributed in aliquot
volumes for storage at —24° C or used for immediate
analysis. At the 34th day, after 14 hr of fasting, urine
was collected (12 hr) in metabolic cages for determi-
nation of creatinine clearance and urinary protein
concentration. At the end of the experiment, the
animals were anesthetized with ether and exsanguin-
ated by aortic puncture. Liver, epididymal fat, and
retroperitoneal fat were removed and immediately
frozen for further analyses.
Analytical methods: Lipid determinations in
serum. Triglycerides were quantitated on an autoan-
alyzer (Technicon AA 2) [5] in isopropanol extracts
from 50-pl samples of serum after treatment with
zeolite. Phospholipids were extracted with 2 ml of
methanollchloroform (1:2) from l00-pi samples of
serum. The solvent of the extracts was evaporated.
The precipitates were oxidized with 100 sl of perch-
loric acid for the determination of phosphorus con-
centration [6]. Total serum cholesterol concentration
was measured from 20-pi serum samples by gas
liquid chromatography on a Hewlett-Packard 5830,
an instrument with autosampler and terminal [7].
Serum-free cholesterol concentration was estimated
from isopropanol extracts using 50-pi serum samples
treated with zeolite [8]. Alpha-cholestane was used
as internal standard. Alpha- and pre-alpha-lipopro-
tein and beta- and prebeta-lipoprotein cholesterol
concentration was determined by gas liquid chroma-
tography after electrophoretic fractionation of 10-l
serum samples in agarose and precipitation of lipo-
proteins with dextran-sulfate-calcium chloride [7].
Total serum fatty acids in 2O-pl of serum samples
were transmethylated with 1 ml of 3% sulfuric acid in
methanol (45 mi 60°C). Subsequently, the mixture
was shaken with 2 ml of an aqueous solution of
sodium bicarbonate for neutralization. Methylated
fatty acids were extracted with heptane (1 ml) for
determination by gas liquid chromatography (col-
umn: 5% DEGS-PS on Supelcoport, 6 feet; I.D. of 3
mm; nitrogen flow at 50 cc/mm; injection tempera-
ture at 200° C; column temperature at 180° C; flame
ionization detector temperature at 250° C; injected
sample volume, 1 l).
Lipid determination in tissue. Tissue from liver
was lyophilized. Quantitative determinations of cho-
lesterol and triglycerides were performed in isopro-
panol extracts (1 ml) from 100 g of the lyophilisates
as described for serum analyses. Correspondingly,
phospholipids were quantitated in methanol-chloro-
form (1:2) extracts from 100 g of tissue. Fatty acids
from liver, retroperitoneal and epididymal fat pads
were determined as methyl esters alter simultaneous
extraction and transmethylation from 50 g of tissue
with 1 ml of 3% sulfuric acid in methanol.
Lipid determination in whole body extracts. In a
separate series of experiments, whole body triglycer-
ides, cholesterol and phospholipids were measured
in the carcass (from which the intestine had been
removed). The minced carcass was extracted with
methanoL/chloroform (1:2). Aliquots were taken, so!-
vent was evaporated, and analyses were carried out
as described above.
Serum and urine analyses. Serum urea (urease-
method and serum glucose (GOD-Perid method)
were measured enzymatically. Serum and urine pro-
teins were measured with the Biuret procedure and
by electrophoretic fractionation on cellulose acetate.
Creatinine clearance was determined as previously
described [91.
Radioimmunoassays (RIA). Immunoreacti ye insu-
lin concentrations were measured from 100-d hepa-
rinized samples by RIA. '251-labeled porcine insulin
and guinea-pig-antibody against porcine insulin were
obtained from Schwarz/Man, Orangeburg, N.Y.
[10]. Immunoreactive glucagon was determined in
duplicates from 100 sl of serum which had been
stabilized with heparin and Trasylol. Procine 125J..
glucagon and rabbit antibody K 964 was used for
radioimmunoassay (kit provided by NOVO Re-
search, Bagsvaerd, Denmark) [11]. The serum sam-
ples were extracted with 96% ethanol for the assay
(180 jslJ 100 p1 serum).
Determination oJ HMG-CoA-reductase activity.
The activity of HMG-CoA-reductase was investi-
gated in the microsomal fraction of freshly homoge-
nized livers according to the procedure of Huber,
Latzin, and Hambrecht [12].
Statistical analyses. All values are given as the
mean value SD. The significance of differences was
tested by Wilcoxon's test for paired samples.
Results
The effect of nephrectomy on growth is listed in
Table 1. There was no significant difference with
respect to weight and length between the three
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Table 1. Weight gain and longitudinal growth
Duration of
uremia
Weight, g Length. cm
Uremic
animals(N=9)
Pair-fed
controls(N=9)
Ad-lib-fed
controls(N=9)
Uremic
animals(N=9)
Pair-fed
controls
(N=9)
Ad-lib-fed
controls(N=9)
DayO
Day 34
P
151±16
139 16
<0.001
158±9
160 18
<0.1
168±9
305 23
<0.001
34±1
35 I
<0.01
34±1
36 1
<0.001
35±0
41 I
<0.001
groups of rats at the day of the second operation (day
0). During the 34-day experimental period, uremic
rats practically failed to grow in length and even lost
weight. PF control animals did not differ with respect
to length, but failed to lose weight. In contrast, a
significant gain both in length and weight was ob-
served in the ad-lib-fed (AL) animals.
Serum urea concentration increased by 30% after
subtotal unilateral nephrectomy and increased to six
times above the control after resection of the contra-
lateral kidney. In the third week, the maximum of
serum urea concentration (x 10) was reached.
Serum urea decreased to seven times the control
value by the 34th day. At the 34th day, creatinine
clearance was 915 32 j4'min in PP control animals
and 157 8.07 in U animals (Fig. 1).
The absence of a nephrotic syndrome was docu-
mented by low urinary protein excretion rates (U
group, 4.77 0.39 mgIl2 hr; PF group, 11.02 1.86
mgll2 hr) and normal serum protein concentrations
(U group, 5.3 0.6 g/100 ml; PF group, 4.8 0.8 g/
100 ml).
Serum triglyceride concentrations did not change
within 5 days after subtotal unilateral nephrectomy.
After resection of the contralateral kidney, however,
triglyceride concentrations rose steadily, reaching a
maximum of eight times the normal concentration in
the fourth week and thereafter declining (Fig. 2).
Serum phospholipid concentrations were 30%
higher after subtotal unilateral nephrectomy. They
increased to a maximum of two times the normal
concentration during the third week and remained
constant thereafter (Fig. 3).
Total serum cholesterol levels were about 1 .4
mmoles/liter (60 mgIlOO ml), and serum free choles-
terol levels were about 0.14 mmoles/Iiter (6 mg/lOO
ml) in control animals. After subtotal unilateral ne-
phrectomy, there was also a 30% increase in total
and free cholesterol concentrations (Fig. 4). After
resection of the contralateral kidney, a steadily pro-
gressive increase occurred until a maximum was
reached in the fourth week. The fractional increase
in serum-free cholesterol was more pronounced than
the fractional increase in total serum cholesterol.
Consequently, the ratio of free cholesterolltotal cho-
lesterol was 1:10 in PF controls and 1:6 in uremic
animals (P 0.01) (Fig. 5).
In uremia, the distribution of cholesterol into the
different lipoprotein fractions was markedly changed
(Fig. 6). In controls, one third of the cholesterol was
detected in lipoproteins which migrated in beta- and
pre-beta-position: two thirds of the cholesterol were
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Fig. 1. Senim urea in igremic rats (N = 9), sham-operatedpair-fed
(N = 9), and sham—operated ad—libfed control rats (N = 9). (u =
uremic; c = pair-fed controls; f = ad-lib-fed controls.)
25 30 35
Time, days
Fig. 2. Serum triglycerides in uremic rats (N = 9), in sham-
operated pair-fed (N 9), and sham-operated ad-lihfed control
rats (N = 9). (See Fig. I for abbreviations used.) (ii, f, c = same as
Fig. I.)
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Fig. 3. Serum p/iosp/zolipids in ure,nic rats (N = 9), in sham-
opera ted pair-fed (N = 9), and s/lam operated ad-/ib:fed control
rats (N =9). (See Fig. 1 for abbreviations used.) ii = uremic: c =pair-
fed controls; f= ad-jib-fed controls.)
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Fig. 4. Total cholesterol and free cholesterol in the serum c/
uremic rats (N = 9), s/lam operated pair-fed (N = 9), and sham-
operated ad-lib-fed control rats (N = 9). For denoting total serum
cholesterol: u uremic; c ----: pair-fed controls, f -. -. -. -: ad-
lib-fed controls. For denoting free cholesterol: u : uremic:
k----: pair-fed controls. The data for the ad-lib-fed control group
are essentially the same as they are for the k group.
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found in the position of alpha- and pre-aipha-lipopro-
teins. Subtotal unilateral nephrectomy caused an in-
crease of approximately 30% in both fractions. Ne-
phrectomy of the contralateral kidney did not alter
the combined levels of beta- and pre-beta-cholesterol
during the following 3 weeks, but it caused an in-
crease in the combined levels of alpha- and pre-
alpha-cholesterol which became even more pro-
nounced after 2 weeks and remained constantly ele-
vated thereafter. After 5 weeks, the combined levels
of beta- and pre-beta-cholesterol were increased two
to three times above the control value.
Total serum fatty acid composition at the begin-
ning and at the end of the experiment is listed in
Table 2. In PF and ad-lib-fed control animals, signifi-
cant time-dependent changes were only observed in
the fraction of polyunsaturated fatty acids: the con-
centration of linoleic acid increased at the expense of
arachidonic acid. This increase was even more pro-
0
'I
C0
I.,
C0
00
C
0
C)
U-
0.20
nounced in uremic animals. The only significant dif-
ference between uremic and PF control animals con-
cerned myristic acid (C14) which decreased from
4.7 to 1.9% in U animals.
In PF controls, immunoreactive serum insulin
(IRI) in the fasting state fell by about 20% from the
beginning to the end of the observation period. The
fall was even more pronounced in uremic rats (Table
3). Immunoreactive serum glucagon concentrations,
measured at the end of the experiment, were higher
in uremic animals when compared with PF controls
and even more so when compared with the ad-lib-fed
controls.
0
SS
0
C0
C,
A- —A
10 20
Time, days
Fig. 5. Changes of the ratio of serum free cholesterol/serum total
cholesterol in uremic rats (u) and in sham-operated pairfed con-
trol rats (c). The data for the ad-lib-fed control group are essen-
tially the same as they are for the pair-fed control group.
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Fig. 6. Change of cholesterol concentration in tile elect rophoreti-
cally separated serum lipoproteins from uremic rats (N =5), from
sha,n-operated pair-fed (N = 5), and from sham-operated ad-jib-
fed control rats (N = 5). u0 = alpha- and pre-alpha-lipoprotein
cholesterol in uremic rats; c, = in pair-fed controls and; f,. = inad-
lib-fed controls. u/3 + prei3 = beta- and pre-beta-lipoprotein cho-
lesterol in uremic rats; cf3 + pref3, in pair-fed controls: and ff3 +
pref3, in ad-lib-fed controls.
146 Heuck et a!
Table 2. Relative composition of total serum fatty acids
Serum fatty acids, % of total fatty acids
C140 C16_0 C,6_1 c,_, C1.3 C20_4
Uremia(N = 10)
day 0 4.7 1.7 19.3 1.6 0.7 0.3 13.6 1.3 9.2 1.4 26.7 2.1 1.9 1.2 23,3 2.7
day 34 1.9 0.7 20.3 1.5 0.5 0.3 12.5 1.1 9.3 1.7 33.4 2.2 2.8 2.2 18.5 3.7
pa <o.ooi NS NS NS NS <0.001 NS <0.01
Pair-fed control(N = 10)
day 0 5.7 2.3 20.4 1.9 0.8 0.4 13.9 2.8 9.0 1.8 24.9 4.1 2.1 0.3 22.3 4.8
day 34 5.0 1.0 20.2 1.5 0.8 0.8 12.0 1.3 8.8 II 30.7 2.7 1.4 1.0 19.5 3.7
DU NS NS NS NS NS <0.001 NS NS
Ad-lib-fed control
(N = 9)
day 0 6.4 1.7 18.3 1.7 0.7 0.2 12.1 1.4 7.1 1.4 24.2 1.9 1.4 0.4 26.4 3.0
day 34 4.4 1.3 20.4 0.7 0.8 0.3 10.6 0.6 8.4 0.6 30.5 1.4 1.5 0.9 22.2 1.2
pa NS NS NS NS NS <0.001 NS <0.001
a Difference between day 0 and day 34 (Wilcoxon-test for pair differences). For differences between groups, see text.
Small, but significant changes were observed in
the phospholipid concentrations of the liver (Table
4). They were about 10% higher in uremia when
compared with PF controls, while no alterations
were found in triglyceride and cholesterol levels.
Triglyceride concentrations were considerably
higher in livers of ad-lib-fed animals. The activity of
HMG-CoA-reductase in liver microsomes was
slightly (— 18%), but not significantly (P <0.1) lower
in uremia (Table 4).
The fatty acid composition in hepatic, retroperito-
neal, and epididymal adipose tissues is summarized
in Table 5. In the liver, no significant differences
were observed between the three groups of animals.
In contrast, the fatty acid composition was signifi-
cantly altered in adipose tissue. In uremia, linoleic
acid (C18_2) was increased by about 30%, while myr-
istic acid (C14_0), palmitic acid (C16_0), and palmito-
leic acid (C16_1) were decreased. The only significant
difference between PF and ad-lib controls concerned
stearic acid (C18_0) and oleic acid (C18_1), which were
lower in ad-lib-fed controls. There was a significant
increase in arachidonic acid (C20_4) in uremic animals
as compared with ad-lib-fed, but not as compared
with PF controls.
In the carcass of uremic animals, there was a
significant (P <0.01) diminution in concentration of
whole body triglycerides as compared to pair-fed
controls (U, 1.48 0.62 g/animals;PF,3.45 1.42gl
animal; AL, 4.81 2.64 glanimal), but there was no
difference in whole body cholesterol (U, 0.23 0.05
g/animal;PF 0.23 0.04 g/animal; AL, 0.27 0.06g/
animal) and phospholipids (U, 10.7 3.4 glanimal;
PF, 11.3 4.2 g/animal; AL, 16.4 5.1 g/animal).
Discussion
In man, chronic uremia is usually accompanied by
type IV hyperlipoproteininemia [13—16]. Serum tri-
glyceride levels are elevated, while cholesterol val-
ues are commonly in the normal range, although they
may occasionally be increased.
The present investigation documents that hyper-
lipoproteinemia is constantly observed in the uremic
rat, with an increase of serum triglycerides, phos-
pholipids, and total cholesterol values, accompanied
by an even more pronounced increase in the fraction
of free cholesterol. Serum triglyceride and serum
phospholipid levels rose slightly, but significantly,
even after unilateral nephrectomy and prior to the
development of uremia, thus raising the question of
whether or not loss of renal parenchyma is one of the
causes contributing to the pathogenesis of uremic
hyperlipoproteinemia. The absence of a nephrotic
syndrome in this animal model of uremia was ex-
Insulin, mU/mi Glucagon, pg/mi
Day 34Day 0 Day 34
Uimic animals (u)(N = 10) 14.4 3.6 6.8 2.9 254 74
Pair-fed controls (c)
(N = 10) 15.2 4.9 10.4 2.2 142 32
Ad-lib-fed controls
(f) (N = 10) 15.9 3.7 12.6 2.1 126 34p
ulf NS <0.001 <0.001
u/c NS <0.01 <0.001
c/f NS NS NS
Table 3. Immunoreactive serum insulin and serum glucagon levels
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Table 4. Lipid concentrations in liver tissue
Triglyceiides
mg/g dry WI
Cholesterol
mg/g dry WI
Phospholipids
mg/g dry wt
HMG-CoA- reductase
pmoles/rnin/mg
protein
Uremia (u) (N = 10)
Pair-fed controls (c) (N = 10)
Ad-lib-fed contnils (t) (N = 9)
P
u/c
u/f
c/f
7.8 1.3
9.3 1.9
20.4 5.5
NS
<0.001
<0.01
6.9 0.9
7.4 0.5
8.7 1.7
NS
NS
NS
101.3 4.6
91.2 6,7
94.5 8.7
<0.01
NS
NS
121 44
130 34
Not determined
NS
cluded by normal serum albumin values and low
urinary protein excretion rates.
in contrast to the usual finding in uremic patients,
serum cholesterol was constantly elevated (approxi-
mately fourfold). HMG-CoA-reductase in the fasting
state was, if anything, slightly reduced. This finding
supports the conclusion that hypercholesterolemia is
not the result of stimulated hepatic cholesterol syn-
thesis. This premise is supported by preliminary ob-
servations, that tritiated water incorporation into
cholesterol is not increased in the liver of uremic
animals (unpublished observations).
The whole body cholesterol value was not in-
creased as it is in the experimental nephrotic syn-
drome [191; this finding would also argue against
hepatic overproduction of cholesterol.
Glucagon has been shown to reduce HMG-CoA-
reductase; it is thus antagonistic to the action of
HMG-CoA-reductase stimulating hormones [18].
Since immunoreactive glucagon levels were consid-
erably increased in uremic animals, the low HMG-
CoA-reductase activity may result from hypergiuca-
gonemia; however, it is known that to a certain
extent immunoreactive glucagon in uremia repre-
sents biologically inactive glucagon [19]. It is con-
ceivable that the catabolic effect of elevated levels of
biologically active hormone may account for reduced
weight and lower insulin levels. In the experimental
nephrotic syndrome, hepatic cholesterol synthesis is
initially increased and is reduced in later stages [20].
Such a terminal decrease in HMG-CoA-reductase in
the uremic animals is unlikely, since in sequential
measurements serum cholesterol, in contrast to
serum triglycerides, remained
the duration of uremia.
An increase of cholesterol
Table 5. Composition of fatty acids in liver and adipose tissue
Fatty acids, % of total fatty acids
C14_0 C16_0 C16_1 C18_0 C18_1 C18_2 C18_3 C20_4
Liver
Uremia <0.4 22.0 l.8 1.0 0.2 21.0 2.7 10.0 1.1 26.3 2.7 2.8 1.8 18.3 1.6(N = 10)
Pair-fed controls <0.4 22.6 1.0 0.7 0.2 20.9 1.2 9.8 0.7 24.7 1.2 1.1 0.7 19.0 1.8(N = 10)
Ad-lib-fed controls <0.4 22.6 0.9 0.7 0.2 17.6 2.2 10.7 1.2 27.5 2.2 1.3 0.8 19.3 1.7
(N = 9)
Uremia 1.4 0.la 16.1 0.6a
Epididymal fat
3.1 0.9a 4.4 0.8 24.1 1.3 43.3 2.0 4.9 0.6 0.9 0.2(N = 10)
Pair-fed controls 1.9 0.1 22.6 1.8 5.3 1.3 4.3 0.7 25.6 1.2 34.0 2.7 4.2 0.4 0.6 0.1(N = 10)
Ad-lib-fed controls 1.8 0.1 21.4 2.2 7.8 0.7 2.6 0.3k' 23.7 08b 35.3 2.8 5.5 0.5 0.4 0.2(N = 9)
Uremia 1.1 0.la 15.1 l.5 Ret roperitoneal fat1.5 0.3a 6.8 0.9 23.6 1.0 44.3 l.5 4.7 0.3 1.0 0.4(N = 10)
Pair-fed controls 1.9 0.2 23.1 2.9 3.0 1.1 7.7 1.3 24.6 1.4 33.0 3.0 4.4 1.3 0.5 0.1(N = 10)
Ad-lib-fed controls 1.8 0.1 24.1 2.2 5.6 1.1 4.1 0.6b 23.9 6.1 33.4 2.2 4.6 0.9 0.4 0.1(N = 9)
a Difference between uremia and pair-fed contmls, P <0.01.
b Difference between pair-fed controls and ad-lib-fed controls, P <0.01.
elevated throughout
was found both in
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serum lipoproteins with beta- and pre-beta-mobility
and with alpha- and pre-aipha-mobility. In contrast
to other experimental models of hyperlipidemia, e.g.
streptozotocin-induced diabetes mellitus [38] or cho-
lesterol-feeding [391, the rise in cholesterol was more
pronounced in the alpha fraction with the higher
electrophoretic mobility. A similar observation was
made in rats treated with 4-aminopyrazolopyrimidin
and high sucrose diet [21] and in the experimental
nephrotic syndrome [22]. In this respect, the rat
differs from the human in whom low alpha-lipopro-
tein concentrations are found in uremia [I]. Interest-
ingly, the increase of cholesterol in beta- and pre-
beta-lipoprotein occurred only when serum triglycer-
ide levels rose, and it occurred considerably later
than the increase of cholesterol in alpha- and pre-
alpha-lipoproteins. In normal rats, free cholesterol
comprises 10% of total cholesterol: in uremic ani-
mals, the relative portion of free cholesterol rose
twofold. Although free cholesterol could not be mea-
sured in the different lipoprotein fractions, the rela-
tive increase in free cholesterol was apparent even 5
days after induction of uremia, when beta- and pre-
beta-lipoproteins and triglyceride levels were still
normal. This finding would suggest that free choles-
terol is mainly transported in the alpha- and pre-
alpha-lipoprotein fraction.
In the rat, esterification of serum cholesterol is not
entirely dependent upon the LCAT-system [231 as it
is in the human. Rather, cholesterol esters are se-
creted by the liver [24]. Therefore, no conclusion
with respect to possible changes in LCAT in uremia
can be drawn from the changes in the ratio of free!
total cholesterol. In uremic patients, serum triglycer-
ide and phospholipid values are commonly above the
normal range [13—16]. Fasting serum glucose is usu-
ally normal, and basal IRI does not show consistent
changes, i.e., it was found to be elevated [25] or
normal [3]. In contrast, immunoreactive glucagon
levels are considerably elevated [19], although im-
munoreactive glucagon is heterogeneous and may
include fractions without biological activity.
In uremia, both renal [26] and extrarenal [27]
metabolism of insulin and renal catabolism of gluca-
gon [18] are impaired, and there is evidence for
peripheral resistance to the action of insulin [281 and
increased susceptibility to glucagon [29]. Hyper-
triglyceridemia may result from abnormalities
in triglyceride production and removal by peripheral
tissues. In one theory, plasma triglyceride eleva-
tion in renal failure has been related to peripheral
insulin resistance [1]. Insulin resistance, how-
ever, cannot entirely explain the hypertriglycer-
idemia observed in uremic animals. Basal IRI fell
with increasing duration of the experiment while
serum triglycerides continued to rise. Basal IRI was
decreased rather than increased as compared with
pair-fed control rats. Insulin secretion has been
shown to be stimulated by potassium [30], but mean
serum potassium concentrations were normal and
did not differ between the two groups.
Increased glucose uptake by the liver, secondary
to an inadequate insulin response during feeding,
stimulates hepatic lipogenesis and stimulates mono-
desaturation of fatty acids [31]. On the other hand,
insulin causes polydesaturation and chain elongation
in the liver [32]. In uremic animals, however, there
were no such changes of either serum fatty acids or
hepatic fatty acids. This finding would indicate, that
there is no stimulation of hepatic synthesis, chain
elongation, or polydesaturation of fatty acids by
either insulin or glucose. Effects resulting from insu-
lin or glucose excess, which were postulated to occur
in uremia [1], cannot be demonstrated in the present
model of experimental uremic hyperlipidemia. Ob-
viously, increased hepatic lipogenesis does not play
an important role in the development of hyperlipo-
proteinemia in experimental uremia.
In experimental uremia, fatty acid oxidation is
known to be reduced as reflected by the respiratory
ratio (Qo2IQco2) [33]. In this study, whole body tri-
glyceride values in uremic animals were found to be
decreased. The decrease in whole body triglyceride
values in the presence of unchanged dietary fat up-
take would be consistent with a diminution of triglyc-
eride synthesis in the liver and/or in adipose tissue.
Since the lipolytic system in adipose tissue is exqui-
sitely sensitive to epinephrine, serum free fatty acid
(FFA) concentrations could not be determined with-
out introducing artefacts resulting from anesthesia or
pain. As reported previously [34], however, basal
adenylate cyclase activity in adipose tissue of uremic
rats is unchanged as is its reaction to epinephrine,
glucagon, or parathyroid hormone (PTH). Since both
glucagon and PTH stimulate adenylate cyclase and
since both hormones are elevated in renal failure,
one might expect elevated serum FFA levels. In
uremic patients, however, FFA are commonly
within the normal range [35].
There were remarkable alterations in the relative
portions of individual fatty acids in adipose tissue.
These changes may reflect alterations in the rate of
fatty acid synthesis and/or in the rate of fatty acid
release. Furthermore, such alterations may also
point to compositional changes with a relative de-
crease of storage fat (in parallel with a decrease in
body weight) and a relative increase of structural fat.
Fatty acid chain elongation and monodesaturation
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